Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

54°
- Mammoth Lakes, CA (93546)
  Today
  
  Sunshine and clouds mixed. High 71F. Winds NW at 5 to 10 mph..
  
  Tonight
  
  Some clouds. Low 32F. Winds NW at 5 to 10 mph.
  
  Updated: March 26, 2026 @ 9:28 am
- Full Forecast

Site search

Home
News
Sports/Outdoors
Events
- Archives
Obituaries
Classifieds
- Place an ad
E-Edition
Special Sections
- Eastern Sierra Fishing Guide
- 2024 Summer Olympics

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)

24.46 +0.66 (+2.78%)

Streaming Delayed Price Updated: 1:29 PM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Catalyst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Recap: Catalyst Pharmaceuticals Q4 Earnings ↗

March 16, 2022

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported its Q4 earnings results on Wednesday, March 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study ↗

March 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Earnings Scheduled For March 16, 2022 ↗

March 16, 2022

Companies Reporting Before The Bell • Ideanomics (NASDAQ:IDEX) is likely to report quarterly loss at $0.05 per share on revenue of $33.20 million. • Tarena...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Earnings Preview For Catalyst Pharmaceuticals ↗

March 15, 2022

Catalyst Pharmaceuticals (NASDAQ:CPRX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-16. Here's what investors need to know before the announcement....

Via Benzinga

The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗

March 13, 2022

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...

Via Benzinga

Catalyst Pharma Expects FY22 Revenue Beat Consensus On Continued Recovery In Macroeconomic, Healthcare Activity ↗

February 07, 2022

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) anticipates

Via Benzinga

47 Biggest Movers From Yesterday ↗

February 08, 2022

Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH...

Via Benzinga

7 of the Top-Rated Pharmaceutical Stocks for Q1 ↗

January 18, 2022

As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks.

Via InvestorPlace

The Top 3 Robinhood Stocks of 2021 ↗

January 07, 2022

The Robinhood trading platform is controversial, but it has drawn investors to many stocks that have posted big gains in the last year.

Via InvestorPlace

If You Invested $1,000 In Catalyst Pharmaceuticals Stock One Year Ago, Here's How Much You'd Have Now ↗

November 30, 2021

Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 ETF Trust (NYSE: SPY) total return over the last 12...

Via Benzinga

Topics Stocks

Catalyst Pharmaceuticals, inc (CPRX) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

CPRX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

3 Low-Priced Stocks That Make Smart Bets ↗

November 08, 2021

There are still plenty of low-priced stocks that would make great additions to your portfolio and have the potential for higher gains.

Via InvestorPlace

Catalyst Pharmaceuticals Stock Reaches Resistance Level, Looks Ready To Break Out ↗

October 06, 2021

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) shares are tra...

Via Benzinga

Why Are Catalyst Pharma Shares Trading Higher On Thursday? ↗

September 30, 2021

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has received a favorable decision from the 11th Circuit Court of Appeals in its appeal to overturn a District Court...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

September 27, 2021

The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may...

Via Benzinga

Catalyst Pharmaceuticals's Return On Capital Employed Overview ↗

September 15, 2021

According to Benzinga Pro, during Q2, Catalyst Pharmaceuticals (NASDAQ:CPRX) earned $15.84 million, a 61.6% increase from the preceding quarter. Catalyst Pharmaceuticals also...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

Catalyst Pharmaceuticals, inc (CPRX) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

CPRX earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

5 Value Stocks In The Healthcare Sector ↗

July 12, 2021

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Catalyst Pharmaceuticals Insights: Return On Capital Employed ↗

June 25, 2021

Catalyst Pharmaceuticals (NASDAQ:CPRX) posted Q1 earnings of $9.80 million, an increase from Q4 of 13.73%. Sales dropped to $30.20 million, a 2.61% decrease between quarters. In...

Via Benzinga

The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs ↗

June 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

Catalyst Pharmaceuticals Insights: Return On Capital Employed ↗

June 09, 2021

Looking at Q1, Catalyst Pharmaceuticals (NASDAQ:CPRX) earned $9.80 million, a 13.73% increase from the preceding quarter. Catalyst Pharmaceuticals's sales decreased to $30.20...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying ↗

May 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Local Events
Obituaries
Multimedia
Online Features

Services

Contact Us
Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Contact Information

MammothTimes.com
645 Old Mammoth Road, Suite A
Mammoth Lakes, CA 93546
Phone: 760-934-3929

Advertising

Retail Sales: egalanski@mammothtimes.com
Classified Sales: sales@mammothtimes.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Consent Preferences

Mammoth Lakes, CA (93546)

Today

Tonight

Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)

All News about Catalyst Pharmaceuticals, Inc. - Common Stock

Sections

Services

Contact Information